ArticleFrontiers in pharmacology2025

Adverse drug reactions to atezolizumab in combination with bevacizumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database.

Wanming He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.